Stockscreener 앱 받기
0.344
4.44%
-0.016
시간 외 거래:
.36
0.016
+4.65%
전일 마감가:
$0.36
열려 있는:
$0.353
하루 거래량:
2.03M
Relative Volume:
4.53
시가총액:
$16.72M
수익:
$1.14M
순이익/손실:
$-56.27M
주가수익비율:
-0.2834
EPS:
-1.2139
순현금흐름:
$-51.94M
1주 성능:
-5.75%
1개월 성능:
-33.22%
6개월 성능:
-67.85%
1년 성능:
-71.57%
1일 변동 폭
$0.338
$0.4067
1주일 범위
$0.338
$0.4159
52주 변동 폭
$0.338
$2.38
웨어울프 테라 Stock (HOWL) Company Profile
명칭
Werewolf Therapeutics Inc
전화
617-952-0555
주소
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.344 | 18.90M | 1.14M | -56.27M | -51.94M | -1.2139 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
웨어울프 테라 Stock (HOWL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-04-03 | 개시 | JMP Securities | Mkt Outperform |
| 2023-08-24 | 개시 | Wedbush | Outperform |
| 2023-06-06 | 재개 | Jefferies | Buy |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-05-25 | 개시 | Evercore ISI | Outperform |
| 2021-05-25 | 개시 | H.C. Wainwright | Buy |
| 2021-05-25 | 개시 | Jefferies | Buy |
| 2021-05-25 | 개시 | SVB Leerink | Outperform |
모두보기
웨어울프 테라 주식(HOWL)의 최신 뉴스
RA Capital adjusts Werewolf Therapeutics (HOWL) stake to 10.6% ownership - Stock Titan
Werewolf Therapeutics Stock (US4433141076): valuation back in focus after recent pipeline updates - AD HOC NEWS
Werewolf Therapeutics Stock (US4433141076): Quarterly earnings keep biotech micro-cap in focus - AD HOC NEWS
Ra Capital sells $253,568 in Werewolf Therapeutics (NASDAQ:HOWL) stock - Investing.com
RA Capital funds trim Werewolf Therapeutics (HOWL) stake with 678K-share sale - Stock Titan
Werewolf Therapeutics director Evnin sells $28,463 in company stock - Investing.com UK
Werewolf Therapeutics (HOWL) entities linked to Luke Evnin sell 76,928 shares - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Werewolf Therapeutics director Luke Evnin sells $43,028 in shares - Investing.com UK
Werewolf Therapeutics director Luke Evnin sells $43,028 in shares By Investing.com - Investing.com India
Werewolf Therapeutics (NASDAQ: HOWL) director’s entities sell shares - Stock Titan
Werewolf Therapeutics director Luke Evnin sells $63,628 in stock - Investing.com
Werewolf Therapeutics director Luke Evnin sells $63,628 in stock By Investing.com - Investing.com Australia
Werewolf Therapeutics (NASDAQ: HOWL) director-affiliated funds sell 139,803 shares - Stock Titan
Werewolf Therapeutics Stock Stalls While HOWL Holds for Strategic Update - Bez Kabli
Werewolf Therapeutics (HOWL) Slips to $0.45 as Biotech Stock Holds Near Critical SupportDark Pool Volume - newsline.com
Werewolf Therapeutics Inc. Q1 2026 Earnings: Narrower Loss Surprises as Pipeline Progress ContinuesCEO Earnings Statement - The Legal Advocate
What's Behind the Recent Insider Selling at Werewolf Therapeutics (HOWL) - Kavout
Werewolf Therapeutics director Luke Evnin sells $66,200 in shares By Investing.com - Investing.com India
Werewolf Therapeutics director Luke Evnin sells $66,200 in shares - Investing.com
Director-linked funds trim Werewolf (NASDAQ: HOWL) stake via 141K-share sale - Stock Titan
[144] Werewolf Therapeutics, Inc. SEC Filing - Stock Titan
Werewolf Therapeutics (HOWL) Slides 7.6% as Shares Test Key Support at $0.43VOLD Alert - The Legal Advocate
MPM-linked funds tied to Werewolf (NASDAQ: HOWL) sell 191,762 shares under plan - Stock Titan
HOWL Q1 2026 Earnings: EPS Beats Estimates as Biotech Continues Pipeline ProgressBook Value Growth - The Legal Advocate
HOWL Q1 2026 Earnings: Narrowed Loss Exceeds Estimates, Stock RisesProfit Announcement - Newser
Werewolf Therapeutics (HOWL) Stages a Modest Rebound: Can the $0.44 Level Hold?Impulse Wave - The Legal Advocate
- The Legal Advocate
Werewolf Therapeutics director Luke Evnin sells $76,363 in stock By Investing.com - Investing.com India
Werewolf Therapeutics director Luke Evnin sells $76,363 in stock - Investing.com UK
Evnin-linked funds sell 171K Werewolf Therapeutics (HOWL) shares - Stock Titan
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Stocktwits
Werewolf Therapeutics (HOWL) Stock: Down -3.84%, Support Test at $0.47 2026-05-18ATR Levels - newser.com
Werewolf Therapeutics (HOWL) price target increased by 12.00% to 7.14 - MSN
Werewolf Therapeutics (HOWL) price target increased by 20.19% to 6.38 - MSN
웨어울프 테라 (HOWL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
웨어울프 테라 주식 (HOWL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Jun 16 '26 |
Sale |
0.37 |
149,625 |
55,361 |
331,414 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Jun 15 '26 |
Sale |
0.39 |
128,770 |
50,220 |
341,353 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Jun 09 '26 |
Sale |
0.37 |
369,800 |
136,826 |
381,717 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Jun 11 '26 |
Sale |
0.38 |
262,503 |
99,751 |
361,229 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Jun 10 '26 |
Sale |
0.37 |
45,923 |
16,992 |
378,666 |
| EVNIN LUKE | Director |
Jun 09 '26 |
Sale |
0.37 |
76,928 |
28,463 |
300,283 |
| EVNIN LUKE | Director |
Jun 08 '26 |
Sale |
0.40 |
60,547 |
24,219 |
377,211 |
| EVNIN LUKE | Director |
Jun 05 '26 |
Sale |
0.40 |
24,946 |
9,978 |
437,758 |
| EVNIN LUKE | Director |
Jun 04 '26 |
Sale |
0.44 |
20,072 |
8,832 |
462,704 |
| EVNIN LUKE | Director |
Jun 01 '26 |
Sale |
0.47 |
80,459 |
37,816 |
542,120 |
2.60%
0.94%
자본화:
|
볼륨(24시간):